| Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer cell 31 (6), 737-754. e6, 2017 | 823 | 2017 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 369 | 2020 |
| Pan-cancer analysis of whole genomes. S Hirano, L Yang, M Juul, CA Purdie, BP O'Neill, R Kabbe, ... Nature 578 (DKFZ-2020-01051), 82-93, 2020 | 152 | 2020 |
| Rare genome-wide copy number variation and expression of schizophrenia in 22q11. 2 deletion syndrome AS Bassett, C Lowther, D Merico, G Costain, EWC Chow, ... American Journal of Psychiatry 174 (11), 1054-1063, 2017 | 87 | 2017 |
| Candidate cancer driver mutations in distal regulatory elements and long-range chromatin interaction networks H Zhu, L Uusküla-Reimand, K Isaev, L Wadi, A Alizada, S Shuai, V Huang, ... Molecular cell 77 (6), 1307-1321. e10, 2020 | 51 | 2020 |
| Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes E Rheinbay, MM Nielsen, F Abascal, G Tiao, H Hornshøj, JM Hess, ... BioRxiv, 237313, 2017 | 46 | 2017 |
| ID1 is critical for tumorigenesis and regulates chemoresistance in glioblastoma R Sachdeva, M Wu, S Smiljanic, O Kaskun, K Ghannad-Zadeh, A Celebre, ... Cancer research 79 (16), 4057-4071, 2019 | 38 | 2019 |
| Combined burden and functional impact tests for cancer driver discovery using DriverPower S Shuai, S Gallinger, LD Stein Nature communications 11 (1), 734, 2020 | 31 | 2020 |
| PCAWG Drivers and Functional Interpretation Working Group. PCAWG Structural Variation Working Group. PCAWG Consortium Analyses of non-coding somatic drivers in 2,658 cancer … E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 23 | 2020 |
| International 22q11. 2DS Brain and Behavior Consortium (2017) Rare genome-wide copy number variation and expression of schizophrenia in 22q11. 2 deletion syndrome AS Bassett, C Lowther, D Merico, G Costain, EWC Chow, ... Am. J. Psychiatry 174, 1054-1063, 2017 | 12 | 2017 |
| Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell LymphomaLenalidomide and Tazemetostat Synergistically Curtail DLBCL KI Tong, S Yoon, K Isaev, M Bakhtiari, T Lackraj, MY He, J Joynt, A Silva, ... Clinical Cancer Research 27 (19), 5401-5414, 2021 | 7 | 2021 |
| Candidate cancer driver mutations in superenhancers and long-range chromatin interaction networks L Wadi, L Uusküla-Reimand, K Isaev, S Shuai, V Huang, M Liang, ... BioRxiv, 236802, 2017 | 7 | 2017 |
| Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma K Isaev, D Ennishi, L Hilton, B Skinnider, KL Mungall, AJ Mungall, ... haematologica 106 (5), 1466, 2021 | 6 | 2021 |
| Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas K Isaev, L Jiang, S Wu, CA Lee, V Watters, V Fort, R Tsai, FJ Coutinho, ... Cell Reports 37 (3), 109873, 2021 | 5 | 2021 |
| A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score HY Yhim, Y Eshet, U Metser, CH Lim, K Lajkosz, K Isaev, M Cooper, ... Blood Advances 4 (22), 5762-5771, 2020 | 5 | 2020 |
| Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature, 1-1, 2023 | | 2023 |
| Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation SA Hershenfeld, V Shelton, M Bakhtiari, L Calvente, K Lajkosz, K Isaev, ... Blood 140 (Supplement 1), 3532-3533, 2022 | | 2022 |
| Identification of Genetic Subtypes in Follicular Lymphoma V Shelton, K Isaev, T Liu, A Silva, R Detroja, M Bakhtiari, L Calvente, ... Blood 140 (Supplement 1), 6371-6373, 2022 | | 2022 |
| In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program K Isaev, T Liu, M Bakhtiari, K Tong, R Goswami, B Lam, I Lungu, ... Haematologica, 2020 | | 2020 |
| Comprehensive analysis of lncRNAs reveals candidate prognostic biomarkers in multiple cancer types K Isaev, L Jiang, CA Lee, R Tsai, F Coutinho, PB Dirks, D Schramek, ... bioRxiv, 861039, 2019 | | 2019 |
Jüri ReimandAssociate professor, Ontario Institute for Cancer Research, University of TorontoVerified email at utoronto.ca
